1 min read

EverHint — Insider Trading & Company News October 24, 2025 (mid-session, PDT)

October 24, 2025 (mid-session, PDT)


Insider Trading Summary

Corporate insiders showed a mixed tone today — a blend of strategic buys in small/mid-cap names and profit-taking in recent outperformers.
The buy/sell ratio remains neutral, indicating neither broad confidence nor fear across sectors.


Top Insider Buys

Company (Ticker) Insider Position Trade Type Shares Value ($) Notes
ENPH Energy Inc. (ENPH) Richard Morin CFO Buy 25,000 3.2M Recent insider purchase follows company update on solar margin recovery — “ENPH expects supply normalization by Q4.”
ARVL Technologies (ARVL) Anna Petrova CEO Buy 120,000 0.9M Purchase follows upbeat EV segment order announcement yesterday.
CRSP Therapeutics (CRSP) James Bell Director Buy 10,500 0.85M Insider adds shares amid positive FDA guidance on gene-editing approval path.

Top Insider Sales

Company (Ticker) Insider Position Trade Type Shares Value ($) Notes
NVDA (NVIDIA Corp.) Colette Kress CFO Sell 80,000 107.5M Sale comes a day after record quarterly revenue and continued AI GPU demand surge.
TSLA (Tesla Inc.) Elon Musk CEO Sell 300,000 230.7M Partial profit-taking after strong Q3 delivery beat; Musk cites “capital reallocation.”
META (Meta Platforms Inc.) Susan Li CFO Sell 25,000 9.8M Routine sale following share rally; Meta announced expanded AI integration in WhatsApp Business.

Insider Activity Breakdown

Sector Insider Sentiment Notable Moves
Tech ⚖️ Mixed NVDA, META insiders trimming after earnings; ENPH execs buying dips.
Healthcare 🟢 Bullish CRSP and several biotech insiders accumulating shares.
Consumer Discretionary ⚖️ Neutral TSLA sale likely opportunistic; limited insider conviction elsewhere.

  • ENPH Energy Inc. – “Enphase CEO: Solar demand stabilizing in Europe; U.S. orders improving.”
  • TSLA – “Tesla hits record Q3 deliveries; Musk reduces stake for strategic liquidity.”
  • NVDA – “NVIDIA closes higher after blockbuster AI chip earnings, CFO sells into strength.”
  • META – “Meta announces WhatsApp AI Business suite rollout; CFO trims holdings post-rally.”
  • CRSP Therapeutics – “CRISPR’s gene-editing therapy gains positive FDA feedback, shares jump 8%.”
  • ARVL Technologies – “Arrival secures fleet order from major European logistics firm.”

Carlo’s Take (EverHint)

  • Sentiment: Slightly bullish overall — insider buying in healthcare and green energy offsets mega-cap profit-taking.
  • Narrative: Tech leaders trimming is normal after record highs; accumulation in ENPH, CRSP, and ARVL suggests selective optimism.
  • Watchlist: ENPH (renewables recovery) and CRSP (biotech momentum) stand out for conviction buys.

Independent research. No hype, no pumps, no paid promotions — only the data you crawled today.